Adrianna L. Glisan

Adrianna L. Glisan

Auto-generated profile, based on publicly available information

Adrianna L. Glisan

Department of Pharmacology & Neuroscience, Creighton University School of Medicine, Omaha, NE 68178, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2024 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
AGAdrianna Glisan
Adrianna Glisan
ENEric Nielsen
Eric Nielsen
TBTaylor Billion
Taylor Billion
AJAli Bin Abdul Jabbar
Ali Bin Abdul Jabbar
AAAditya Avula
Aditya Avula
ATAbubakar Tauseef
Abubakar Tauseef
Background: Colorectal cancer (CRC) screening via colonoscopy is now advised for most adults beginning at age 45 years, an update from the earlier recommendation of age 50 years. With the increase in CRC screening rates, it is crucial to examine how mortality rates have changed over time. The aim of this study is to identify trends and regional differences in CRC mortality over the last two decades, specifically in individuals within the CRC recommended screening age group. Methods: This study used the Center for Disease Control’s Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) system to collect data on CRC mortality for people ages 45–84 years in the United States from 1999–2022. Results: During the study period, the overall age-adjusted mortality rate (AAMR) for CRC decreased across all census regions. The Midwest consistently had the highest AAMR, while the West had the lowest. Among genders, males in the Northeast had the highest rates, whereas females in the West had the lowest. Black or African Americans in the Midwest experienced the highest AAMR among racial groups, while Asian or Pacific Islanders in the Midwest had the lowest AAMR. Conclusions: The mortality rate of CRC has been decreasing since 1999, but differences between regional groups have persisted. Disparities in outcomes still exist, showing that vulnerable subgroups require targeted interventions such as improved screening and follow-up access to increase early-stage diagnoses and potential for curative treatments.

28 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
PRParisa Rafiei
Parisa Rafiei
HMHuda Saadia Mian
Huda Saadia Mian
SIShruthi H. Iyer
Shruthi H. Iyer
Samantha Brittany DravesSamantha Brittany Draves
Samantha Brittany Draves
SMStephanie A. Matthews
Stephanie A. Matthews
KSKristina A. Simeone
Kristina A. Simeone
Background/Objectives: Hyperexcitable neuronal activity associated with seizures may disrupt brain homeostasis resulting in abnormal glucose and nutrient management and metabolism. Specialized ependymal cells known as tanycytes line the third ventricle wall bridging communication between the brain, CSF, and blood. Despite their positional importance, whether tanycytes are impacted by epilepsy is unknown. Here, known protein markers of tanycytes were assessed in the Kcna1-null mouse model of genetic epilepsy with spontaneous recurrent seizures (SRS mice). Further, whether an anti-seizure metabolic ketogenic diet (KD), previously proven effective in SRS mice, restored protein levels was determined. Methods: Known tanycyte proteins, including glucose transporter 1 (GLUT1), glial fibrillary acidic protein (GFAP), and doublecortin (DCX, to determine potential neurogenic differences) were examined throughout the anterior–posterior axis of the third ventricle using immunofluorescent histochemistry. Results: Decreased GLUT1 immunoreactivity and elevated GFAP levels were found in the SRS cohorts. The number of neurogenic DCX-expressing cells did not differ. Two weeks of KD treatment reduced GFAP to WT levels. GLUT1 remained low in KD-treated SRS mice. Conclusions: These data suggest that the expression of proteins important for the structure and function of tanycytes is altered in preclinical epilepsy and is differentially restored with KD treatment. Whether tanycytes actively participate in the pathophysiology of epilepsy or associated comorbidities is an intriguing possibility given their integral role in brain homeostasis.